David L. Amrani

1.2k total citations
24 papers, 921 citations indexed

About

David L. Amrani is a scholar working on Hematology, Immunology and Allergy and Molecular Biology. According to data from OpenAlex, David L. Amrani has authored 24 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 9 papers in Immunology and Allergy and 7 papers in Molecular Biology. Recurrent topics in David L. Amrani's work include Cell Adhesion Molecules Research (9 papers), Blood properties and coagulation (6 papers) and Mesenchymal stem cell research (4 papers). David L. Amrani is often cited by papers focused on Cell Adhesion Molecules Research (9 papers), Blood properties and coagulation (6 papers) and Mesenchymal stem cell research (4 papers). David L. Amrani collaborates with scholars based in United States, France and Canada. David L. Amrani's co-authors include Michael W. Mosesson, Anthony B. Chen, Delara Motlagh, Thomas E. Hudson, Jeremy S. Duffield, Bing Li, Marco A. Costa, Timothy D. Henry, Douglas W. Losordo and Kenneth Story and has published in prestigious journals such as Circulation, Blood and Journal of the American College of Cardiology.

In The Last Decade

David L. Amrani

24 papers receiving 871 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David L. Amrani United States	13	345	307	201	175	143	24	921
Stephan Söder Germany	19	326 0.9×	177 0.6×	78 0.4×	102 0.6×	141 1.0×	57	1.2k
Lawrence H. Chow Canada	12	388 1.1×	216 0.7×	45 0.2×	168 1.0×	86 0.6×	16	892
Andrew H. Schulick United States	12	648 1.9×	297 1.0×	55 0.3×	104 0.6×	241 1.7×	14	1.3k
Karin Daub Germany	16	466 1.4×	258 0.8×	62 0.3×	159 0.9×	70 0.5×	17	1.3k
Beate M. Rüger Austria	16	225 0.7×	233 0.8×	117 0.6×	89 0.5×	71 0.5×	28	970
Selina Vergel United States	10	219 0.6×	241 0.8×	24 0.1×	95 0.5×	122 0.9×	10	592
Longbiao Yao United States	18	369 1.1×	84 0.3×	102 0.5×	351 2.0×	67 0.5×	24	1.3k
Shu Sun Denmark	17	324 0.9×	140 0.5×	60 0.3×	114 0.7×	208 1.5×	45	1.2k
Josef Mueller‐Hoecker Germany	16	333 1.0×	340 1.1×	213 1.1×	28 0.2×	71 0.5×	24	1.0k
Sybille Albrecht Germany	20	314 0.9×	129 0.4×	252 1.3×	169 1.0×	163 1.1×	35	1.4k

Countries citing papers authored by David L. Amrani

Since Specialization

Citations

This map shows the geographic impact of David L. Amrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Amrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Amrani more than expected).

Fields of papers citing papers by David L. Amrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Amrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Amrani. The network helps show where David L. Amrani may publish in the future.

Co-authorship network of co-authors of David L. Amrani

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Amrani. A scholar is included among the top collaborators of David L. Amrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Amrani. David L. Amrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kumar, Arun, Didier Rouy, David A. Turner, et al.. (2012). Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model. Catheterization and Cardiovascular Interventions. 81(6). 970–977. 11 indexed citations

Losordo, Douglas W., Timothy D. Henry, Charles J. Davidson, et al.. (2011). Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina. Circulation Research. 109(4). 428–436. 331 indexed citations

Li, Bing, et al.. (2010). Mobilized Human Hematopoietic Stem/Progenitor Cells Promote Kidney Repair After Ischemia/Reperfusion Injury. Circulation. 121(20). 2211–2220. 134 indexed citations

Zubair, Abba C., Sunita Malik, Masakazu Ishikawa, et al.. (2010). Evaluation of mobilized peripheral blood CD34+ cells from patients with severe coronary artery disease as a source of endothelial progenitor cells. Cytotherapy. 12(2). 178–189. 19 indexed citations

McKenna, David H., Darin Sumstad, Diane Kadidlo, et al.. (2010). CD34+ cell selection using small-volume marrow aspirates: a platform for novel cell therapies and regenerative medicine. Cytotherapy. 12(2). 170–177. 6 indexed citations

Motlagh, Delara, Amy Cohen, Kenneth Story, et al.. (2009). Phase 2 Study of Intramyocardial Injection of Autologous CD34+ Cells to Treat Subjects with Refractory Chronic Myocardial Ischemia (CMI): Factors Influencing Mobilization and Apheresis.. Blood. 114(22). 3227–3227. 2 indexed citations

Amrani, David L., et al.. (2003). Cardiovascular disease: potential impact of stem cell therapy. Expert Review of Cardiovascular Therapy. 1(3). 453–461. 10 indexed citations

Amrani, David L., et al.. (2001). Wound Healing. Annals of the New York Academy of Sciences. 936(1). 566–579. 54 indexed citations

Donaldson, Donald J., James T. Mahan, David L. Amrani, David H. Farrell, & Joan H. Sobel. (1994). Further Studies on the Interaction of Migrating Keratinocytes with Fibrinogen. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 2(4). 299–308. 4 indexed citations

10.

Gartner, T. Kent, et al.. (1994). Characterization of Adhesion of Resting and Stimulated Platelets to Fibrinogen and Its Fragments. Annals of the New York Academy of Sciences. 714(1). 303–305. 3 indexed citations

11.

Samad, Fahumiya, Gerald Bergtrom, Hala F. Eissa, & David L. Amrani. (1993). Stimulation of chick hepatocyte fibronectin production by fibroblast-conditioned medium is due to interleukin 6. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1181(3). 207–213. 14 indexed citations

12.

Amrani, David L., Jonathan B. Rosenberg, Fahumiya Samad, Gerald Bergtrom, & David K Banfield. (1993). Developmental expression of chicken antithrombin III is regulated by increased RNA abundance and intracellular processing. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1171(3). 239–246. 1 indexed citations

13.

Gartner, T. Kent, et al.. (1993). Characterization of adhesion of “resting” and stimulated platelets to fibrinogen and its fragments. Thrombosis Research. 71(1). 47–60. 44 indexed citations

14.

Rosenberg, Jonathan B., Peter J. Newman, Michael W. Mosesson, Marie‐Claude Guillin, & David L. Amrani. (1993). Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.. PubMed. 69(3). 217–20. 10 indexed citations

15.

Rosenberg, Jonathan B., Peter J. Newman, Michael W. Mosesson, Marie‐Claude Guillin, & David L. Amrani. (1993). Paris I Dysfibrinogenemia: A Point Mutation in Intron 8 Results in Insertion of a 15 Amino Acid Sequence in the Fibrinogen γ-Chain. Thrombosis and Haemostasis. 69(3). 217–220. 10 indexed citations

16.

Shalev, Yoseph, Dianne Zwicke, Rami Gal, et al.. (1990). Elevated blood levels of platelet activating factor in patients with unstable angina. Journal of the American College of Cardiology. 15(2). A129–A129. 3 indexed citations

17.

Donaldson, Donald J., James T. Mahan, David L. Amrani, & Jacek Hawiger. (1989). Fibrinogen-mediated epidermal cell migration: Structural correlates for fibrinogen function. Journal of Cell Science. 94(1). 101–108. 23 indexed citations

18.

Benecky, Michael J., Carl G. Kolvenbach, David L. Amrani, & Michael W. Mosesson. (1988). Evidence that binding to the carboxyl-terminal heparin-binding domain (Hep II) dominates the interaction between plasma fibronectin and heparin. Biochemistry. 27(19). 7565–7571. 39 indexed citations

19.

Amrani, David L., Michael W. Mosesson, & Takehiko Koide. (1985). Evidence that chicken antithrombin III is a developmentally regulated glycoprotein synthesized by hepatocytes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 847(3). 324–334. 4 indexed citations

20.

Grieninger, Gerd, et al.. (1983). HORMONAL REGULATION OF FIBRINOGEN SYNTHESIS IN CULTURED HEPATOCYTES*. Annals of the New York Academy of Sciences. 408(1). 469–489. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact